drugset / Trial / NCT04209218

Intraoperative Blood Pressure Management and Dexamethasone in Lung Cancer Surgery

NCT04209218 ↗

Recruiting 1988 enrolled Peking University First Hospital
RandomizedFactorialDouble-blindPrevention

Summary

Surgery is the front-line therapy for non-small cell lung cancer (NSCLC) but postoperative complications remains high and patients' long-term outcome is still challenging. In addition to surgery, anesthetic management particularly intraoperative blood pressure management and use of dexamethasone may affect patients' early and long-term outcomes after surgery for NSCLC. This study aims to investigate the impact of intraoperative blood pressure management and dexamethasone administration on early and long-term outcomes in patients undergoing surgery for lung cancer.

Timeline

Start
2020-04-07
Primary completion
2026-12
Completion
2029-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 10 mg —

Indications